Prednisolone levels in plasma and leukemia cells during therapy of chronic lymphocytic leukemia
β Scribed by N. S. Panesar; C. C. Bird; B. E. Roberts; J. A. Child
- Publisher
- John Wiley and Sons
- Year
- 1984
- Tongue
- English
- Weight
- 404 KB
- Volume
- 73
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: Interleukin 6 (il-6) is a b-cell growth and differentiation factor, which may promote the growth of b-cell neoplasms. in chronic lymphocytic leukemia (cll) patients, il-6 plasma levels increased in a stage-dependent manner, suggesting that il-6 may be a useful prognostic marker. the
## Abstract Circulating blood plasma contains proteinaseβdegraded forms of thrombomodulin that are soluble. We quantitatively assayed the plasma levels of thrombomodulin in 15 patients with chronic myelogenous leukemia (CML) in chronic phase by method of an enzymelinked immunosorbent assay using a